Jiangsu Jibeier Pharmaceutical Co Ltd (688566.SS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE100004041

Price
26.80 CNY
Market cap
5.33 bn CNY
P/E (2025)
20.62
P/S (2025)
5.53
Dividend yield
1.94 %
Net margin
26.81 %
Return on equity (ROE)
10.64 %
Return on assets (ROA)
9.52 %

Jiangsu Jibeier Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue896.53 m CNY964.93 m CNY
Gross profit801.28 m CNY964.93 m CNY
Operating income254.66 m CNY252.76 m CNY
EBIT253.60 m CNY298.21 m CNY
Net income219.33 m CNY258.67 m CNY
Diluted EPS – continuing operations1.13 CNY1.30 CNY

Full history since 2016, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Jiangsu Jibeier Pharmaceutical Co Ltd

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company's products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in tablets, capsules, and eye drops forms. Jiangsu Jibeier Pharmaceutical Co., Ltd. was founded in 2001 and is based in Zhenjiang, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.